Enzalutamide Capsule 40mg.
₹ 25,781.00
Palbociclib Capsules 125 mg contains Palbociclib 125 mg, an anticancer medication used for the treatment of certain types of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer. It belongs to a class of medicines known as cyclin-dependent kinase (CDK) 4/6 inhibitors, which work by slowing the growth and multiplication of cancer cells. Palbociclib is commonly prescribed in combination with hormonal therapies to help improve treatment outcomes in patients with advanced or metastatic breast cancer.
As directed by the oncologist or physician.
The dosage and duration of treatment depend on the patient's condition, response to therapy, and accompanying medications. Capsules should be taken exactly as prescribed.
Palbociclib Capsules 125 mg is indicated for:
HR-positive, HER2-negative advanced breast cancer
HR-positive, HER2-negative metastatic breast cancer
Combination therapy with aromatase inhibitors
Find answers to the most common questions about our services.
